Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Medifast, Inc. (MED)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
184.17+3.66 (+2.03%)
At close: 04:00PM EDT
184.76 +0.59 (+0.32%)
After hours: 04:53PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
MACD

MACD

Previous Close180.51
Open178.05
Bid176.76 x 1000
Ask184.52 x 1000
Day's Range177.00 - 184.35
52 Week Range154.67 - 295.38
Volume120,860
Avg. Volume121,000
Market Cap2.12B
Beta (5Y Monthly)1.32
PE Ratio (TTM)13.14
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield6.56 (3.56%)
Ex-Dividend DateJun 27, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
87% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for MED

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • MEDIFAST INC
    MED: Raising target price to $194.00MEDIFAST INC has an Investment Rating of HOLD; a target price of $194.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • PR Newswire

    Health is Top Priority for Majority of U.S. Adults Despite Continuous Cycle of Failed Diets

    Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today announced findings from a company-sponsored survey* exploring U.S. adults' dieting patterns and perspectives on health. According to the survey, 70% of U.S. adults consider their health to be a top priority in life, the most common response even ahead of family and career. Yet, fully half of all U.S. adults find it hard to prioritize their health, citing lack of time and po

  • PR Newswire

    Medifast, Inc. Announces Quarterly Dividend

    Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, announced today that its Board of Directors has declared a $1.64 quarterly cash dividend to its stockholders. The quarterly cash dividend of $1.64 per share is payable on August 8, 2022 to stockholders of record as of the close of business on June 28, 2022.

  • PR Newswire

    Medifast, Inc. to Present at the Jefferies Consumer Conference

    Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, announced today that Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer, will meet with investors and participate in a fireside chat at the Jefferies Consumer Conference, to be held June 20-22, 2022 in Nantucket, MA.

Advertisement
Advertisement